Dr. Madhu Unnikrishnan, MBBS
What this data tells you about Dr. Unnikrishnan
Dr. Madhu Unnikrishnan is a hematology & oncology specialist in Palm Coast, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Unnikrishnan performed 52,619 Medicare services across 2,715 unique beneficiaries.
Between the years covered by Open Payments, Dr. Unnikrishnan received a total of $1,404 from 17 pharmaceutical and/or device companies across 31 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Unnikrishnan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Oxaliplatin chemotherapy injection | 11,800 | $0 | $12 |
| Iron infusion (Feraheme) | 9,180 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 8,710 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 7,940 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 6,780 | $18 | $51 |
| Dexamethasone injection (steroid) | 1,344 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,320 | $8 | $29 |
| Blood draw (venipuncture) | 1,292 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 790 | $1 | $28 |
| Drug injection, under skin or into muscle | 521 | $10 | $69 |
| Office visit, established patient (20-29 min) | 430 | $67 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 292 | $0 | $9 |
| Office visit, established patient (30-39 min) | 279 | $87 | $339 |
| Administration of chemotherapy into vein, 1 hour or less | 251 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 184 | $21 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 141 | $47 | $189 |
| Office visit, established patient, complex (40-54 min) | 115 | $133 | $474 |
| Injection, zoledronic acid, 1 mg | 113 | $7 | $69 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 102 | $16 | $59 |
| Injection of additional new drug or substance into vein | 99 | $11 | $61 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 98 | $1 | $6 |
| Initial hospital admission, high complexity | 96 | $137 | $556 |
| Prothrombin time test (blood clotting) | 92 | $4 | $15 |
| Hospital follow-up visit, high complexity | 90 | $93 | $284 |
| Administration of additional new drug or substance into vein, 1 hour or less | 77 | $49 | $178 |
| Administration of chemotherapy into vein, each additional hour | 72 | $22 | $79 |
| Injection of drug or substance into vein | 69 | $28 | $156 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 56 | $24 | $89 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 51 | $14 | $56 |
| Injection, diphenhydramine hcl, up to 50 mg | 37 | $1 | $3 |
| New patient office visit (30-44 min) | 35 | $86 | $296 |
| Hospital follow-up visit, moderate complexity | 29 | $63 | $197 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 28 | $3 | $11 |
| Automated urinalysis | 25 | $2 | $8 |
| New patient office visit, complex (60-74 min) | 19 | $153 | $585 |
| Infusion, normal saline solution , 1000 cc | 18 | $2 | $7 |
| Drawing of blood for a medical problem | 16 | $66 | $277 |
| New patient office visit (45-59 min) | 16 | $119 | $453 |
| Office visit, established patient (10-19 min) | 12 | $37 | $147 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (76%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Unnikrishnan is a mixed practice specialist, with above-average Medicare volume (top 15% in FL), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Unnikrishnan experienced with oxaliplatin chemotherapy injection?
Does Dr. Unnikrishnan receive payments from pharmaceutical companies?
How do Dr. Unnikrishnan's costs compare to other hematology & oncology specialists in Palm Coast?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology